Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Apricus Biosciences Company Profile (NASDAQ:APRI)

Consensus Ratings for Apricus Biosciences (NASDAQ:APRI) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.45 (26.29% upside)

Analysts' Ratings History for Apricus Biosciences (NASDAQ:APRI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/16/2014ZacksDowngradeNeutral -> Underperform$1.90ViewTweet This Rating  Share This Rating on StockTwits
5/27/2014Cantor FitzgeraldUpgradeHold -> Buy$2.50 -> $3.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2014Cantor FitzgeraldBoost Price Target$2.00 -> $2.50ViewTweet This Rating  Share This Rating on StockTwits
8/23/2013Cantor FitzgeraldInitiated CoverageHold$2.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013JMP SecuritiesLower Price TargetMarket Outperform$6.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
7/27/2012Lazard LtdInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
7/23/2012Ascendiant Capital MarketsInitiated CoverageStrong-Buy$6.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2012 forward)